文献速递水电解质与酸碱慢性肾脏病

急性重度高钾血症后长期死亡率与血钾轨迹

Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

这项回顾性观察研究纳入2016年1月至2017年3月西班牙急诊科172次急性重度高钾血症(血钾>6 mEq/L)发作,共160例患者,评估血钾轨迹与长期全因死亡的关系。中位随访17.3个月,42.5%患者死亡;急性发作时血钾水平不预测死亡,而出院后血钾纵向轨迹可预测全因死亡(总体P=0.0015)。

要点

  • 急性重度高钾血症发作时血钾水平不预测长期死亡。
  • 出院后血钾轨迹可预测全因死亡,总体P=0.0015。
  • 从高钾(>5.5 mEq/L)转为正常血钾(≤5.5 mEq/L)与死亡风险呈负相关。

核心结论

  • 急性重度高钾血症发作前的血钾水平不预测死亡率。
  • 急性发作后系列血钾轨迹可预测死亡风险。
  • 从高钾转为正常血钾与死亡风险呈负相关。

研究设计与样本

  • 回顾性观察研究,检索西班牙瓦伦西亚Dr Peset大学医院2016年1月至2017年3月实验室数据库。
  • 纳入急诊科无溶血急性重度高钾血症(血钾>6 mEq/L)患者。
  • 共172次急性高钾血症发作,涉及160例患者。
  • 采用可处理时间依赖暴露建模的回归方法评估血钾与死亡的多变量校正关联。

主要发现

  • 患者平均年龄77±12岁,60.5%为男性。
  • 最常见合并症为CKD(71.2%)、心衰(35%)和糖尿病(56.9%),仅11.9%接受慢性透析。
  • 急性发作时平均血钾6.6±0.6 mEq/L(范围6.1-9.2),平均eGFR 23±16 mL/min/1.73 m2(范围2-84)。
  • 中位随访17.3(2.2-23.7)个月,68例死亡(42.5%)。
  • 随访监测患者中39.5%出现高钾复发(血钾>5.5 mEq/L)。

关键数值与推荐

  • 急性重度高钾血症定义为血钾>6 mEq/L。
  • 高钾复发定义为血钾>5.5 mEq/L。
  • 出院后血钾轨迹预测全因死亡,总体P=0.0015。
  • 从血钾>5.5 mEq/L转为≤5.5 mEq/L与死亡风险呈负相关。

临床怎么用

  • 急性重度高钾血症发作时血钾水平不宜用于长期死亡风险分层。
  • 出院后应系列监测血钾轨迹以评估长期死亡风险。
  • 促进高钾转为正常血钾可能有助于降低死亡风险。

局限性

  • 单中心回顾性观察研究。
  • 需要进一步证据确认这些发现。
  • 长期管理这些患者的最佳策略尚需明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that is associated with a higher risk of adverse clinical events such as ventricular arrhythmias and sudden cardiac death. Currently, data regarding the prognostic implications of chronic hyperkalaemia are available; however, information about the long-term clinical consequences after an episode of severe hyperkalaemia remains scarce. The objective of this study was to evaluate the association between the trajectory of potassium measurements in patients with acute hyperkalaemia and long-term all-cause mortality. METHODS: This is a retrospective observational study that included patients with acute severe hyperkalaemia [potassium (K) >6 mEq/L] without haemolysis in the emergency room of Dr Peset University Hospital in Valencia, Spain searching the lab database from January 2016 to March 2017. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modelling. RESULTS: We found 172 episodes of acute hyperkalaemia in 160 patients in the emergency room. The mean ± standard deviation age of the sample was 77 ± 12 years and 60.5% were males. The most frequent comorbidities were CKD (71.2%), HF (35%) and diabetes mellitus (56.9%). Only 11.9% of the patients were on chronic dialysis. A quarter of the patients did not have previous CKD, making hyperkalaemia an unpredictable life-threatening complication. During the acute episode, mean potassium and estimated glomerular filtration rate (eGFR) were 6.6 ± 0.6 (range 6.1-9.2) mEq/L and 23 ± 16 (range 2-84) mL/min/1.73 m2, respectively. After a median (interquartile range) follow-up of 17.3 (2.2-23.7) months, 68 patients died (42.5%). Recurrences of hyperkalaemia (K >5.5 mEq/L) were detected in 39.5% of the patients who were monitored during follow-up. We found that previous potassium levels during an acute severe hyperkalaemia episode were not predictors of mortality. Conversely, the post-discharge longitudinal trajectories of potassium were able to predict all-cause mortality (overall P = 0.0015). The effect of transitioning from hyperkalaemia to normokalaemia (K >5.5 mEq/L to K ≤5.5 mEq/L) after the acute episode was significant, and inversely associated with the risk of mortality. CONCLUSIONS: Potassium levels prior to a severe hyperkalaemic event do not predict mortality. Conversely, following an episode of acute severe hyperkalaemia, serial kinetics of potassium trajectories predict the risk of death. Further evidence is needed to confirm these findings and clarify the optimal long-term management of these patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Gorriz JL, D'Marco L, Pastor-González A, et al. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia. Nephrol Dial Transplant. 2022. PMID: 33508124. doi:10.1093/ndt/gfab003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。